companydata.dkcompanydata.dk

PHARMADANICA A/S: Financial statements 2021

CVR: 19056007

Source: annual report 2021, Danish Business Authority

01/04/2020 – 31/03/2021

PHARMADANICA A/S (CVR 19056007) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -792,362 compared with DKK -777,008 the year before. Equity in the 2021 report amounted to DKK 18,079,999. The solvency ratio was 92.2%.

Profit/Loss
DKK -792,362
Equity
DKK 18,079,999
Total Assets
DKK 19,618,267

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021---792K18.1M-
2020---777K18.9M-
2019--3.3M19.6M-
2017--12.9M16.3M-
2016---18K3.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PHARMADANICA A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Alexandre Pierre Jean Vialatte joins PHARMADANICA A/S as directorNov 30, 2021

As of November 30, 2021, Alexandre Pierre Jean Vialatte is registered as director of PHARMADANICA A/S.

Poul Lindof steps down as økonomidirektør of PHARMADANICA A/SNov 30, 2021

As of November 30, 2021, Poul Lindof has stepped down as økonomidirektør of PHARMADANICA A/S.

About PHARMADANICA A/S

PHARMADANICA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE NR. 4943. The management consists of Jean-Marc Pierre Rene Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre Rene Leccia. The company is owned by MISSIONPHARMA A/S. The company has 3 employees (2004). In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385.

Source: annual report 2026, Danish Business Authority